iWriteGigs

Fresh Grad Lands Job as Real Estate Agent With Help from Professional Writers

People go to websites to get the information they desperately need.  They could be looking for an answer to a nagging question.  They might be looking for help in completing an important task.  For recent graduates, they might be looking for ways on how to prepare a comprehensive resume that can capture the attention of the hiring manager

Manush is a recent graduate from a prestigious university in California who is looking for a job opportunity as a real estate agent.  While he already has samples provided by his friends, he still feels something lacking in his resume.  Specifically, the he believes that his professional objective statement lacks focus and clarity. 

Thus, he sought our assistance in improving editing and proofreading his resume. 

In revising his resume, iwritegigs highlighted his soft skills such as his communication skills, ability to negotiate, patience and tactfulness.  In the professional experience part, our team added some skills that are aligned with the position he is applying for.

When he was chosen for the real estate agent position, he sent us this thank you note:

“Kudos to the team for a job well done.  I am sincerely appreciative of the time and effort you gave on my resume.  You did not only help me land the job I had always been dreaming of but you also made me realize how important adding those specific keywords to my resume!  Cheers!

Manush’s story shows the importance of using powerful keywords to his resume in landing the job he wanted.

Mastery EAQ Ch. 26

Navigation   » List of Schools  »  International College of Health Sciences  »  Nursing  »  Nursing 1141- Pharmacology  »  Fall 2022  »  Mastery EAQ Ch. 26

Need help with your exam preparation?

Below are the questions for the exam with the choices of answers:

Question #1
A  The dose will be decreased.
B  The medication will be stopped.
C  The dose will be increased.
D  The dose will be unchanged.
Question #2
A  Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B  Not a candidate for fondaparinux based on an insufficient creatinine clearance
C  Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
D  Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
Question #4
A  Within normal limits
B  Significantly decreased
C  Inadequate to evaluate treatment
D  Significantly elevated
Question #5
A  Assess for dysrhythmias.
B  Administer prescribed vitamin K if bruising is observed.
C  Stop the medication if the systolic blood pressure drops below 110 mm Hg.
D  Monitor liver enzymes.
Question #6
A  Administering the medication intramuscularly in the vastus lateralis
B  Checking if the patient’s prescription contains enoxaparin
C  Massaging the site after the injection
D  Administering the medication when convenient
Question #7
A  “I refrain from drinking coffee and citrus fruit juices daily.”
B  “I take ginkgo supplements for memory enhancement.”
C  “I eat 1 cup of green leafy vegetables daily.”
D  “I do not take aspirin for pain relief.”
Question #8
A  “I avoid tight-fitting stockings or leggings.”
B  “I get up and walk around at least once an hour.”
C  “I’ve been on prolonged bed rest.”
D  “I never sit with my legs crossed at the knees.”
Question #11
A  Platelet count, Heart rate, Blood pressure
B  Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
C  Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
D  Heart rate, Hemoglobin, Blood pressure
Question #12
A  “I will store the bottle in a dry place.”
B  “I will take the medication with food.”
C  “I will use the medication within 60 days after it is opened.”
D  “I will place the pills in an organizer for easy use.”
Question #13
A  Platelet count of 80,000/mm3
B  Diagnosis of diabetes mellitus
C  Creatinine clearance of 25 mL/min
D  Loss of 10 pounds
Question #14
A  The dosage of the amiodarone will be decreased by half.
B  The dosage of the amiodarone will be increased by half.
C  The dosage of the warfarin will be increased by half.
D  The dosage of the warfarin will be decreased by half.
Question #15
A  Monitor the patient for decreased action of the anticoagulant.
B  Monitor the patient for increased action of the anticoagulant.
C  Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D  Continue to administer cimetidine with each dose of warfarin.
Question #16
A  Local thrombosis from a peripheral intravenous line
B  Severe chest pain for the past 2 hours
C  Gastrointestinal bleed
D  Peptic ulcer disease
Question #17
A  Monitor the patient and check the therapeutic range.
B  Notify the health care provider immediately.
C  Increase the dose of heparin.
D  Stop the medication.
Question #18
A  Outside the expected target therapeutic level of anticoagulation; it is too high
B  Within the expected target therapeutic level of anticoagulation
C  Outside the expected target therapeutic level of anticoagulation; it is too low
D  Cannot be interpreted without knowing the prothrombin time and international normalized ratio
Question #19
A  Platelet count: 100,000/mm3
B  Prothrombin time: 13 sec
C  Hemoglobin level: 11 g/dL
D  Leukocyte count: 3000 cells/mm3
Question #20
A  Atrial fibrillation, History of myocardial infarction
B  History of myocardial infarction, Chronic obstructive pulmonary disease
C  Peptic ulcer disease, Chronic kidney disease
D  Chronic obstructive pulmonary disease, Atrial fibrillation
Question #21
A  Platelet count of 95,000/mm3
B  Potassium level of 3.5 mEq/L
C  Activated partial thromboplastin time (aPTT) of 37 seconds
D  International normalized ratio (INR) of 1
Question #22
A  Outside the expected target therapeutic level of anticoagulation; it is too low
B  Outside the expected target therapeutic level of anticoagulation; it is too high
C  The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D  Within the expected target therapeutic level of anticoagulation
Question #23
A  “Discard the drug within 21 days of opening the original container.”
B  “Store the drug with the desiccant-drying agent in the packing cap.”
C  “Remove from the original package and place in aluminum foil.”
D  “Refrigerate and keep away from direct sunlight.”
Question #25
A  Monitor the patient’s laboratory values correctly.
B  Teach the patient about dietary restrictions while on the medication.
C  Have protamine sulfate readily available at all times.
D  Ensure that a loading dose was initially administered when beginning
Question #26
A  Administer protamine sulfate IV.
B  Wait for the INR to decrease.
C  Administer vitamin K1 (phytonadione) IV.
D  Stop the intravenous (IV) drip.
Question #27
A  Prevention of new clots from forming
B  Dissolution of the clot that caused the heart attack
C  A quick decrease in pain
D  Reversal of damage from the infarction
Question #28
A  “I should follow a low-cholesterol diet during the therapy.”
B  “I should take oral contraceptives during the therapy.”
C  “I should refrain from eating broccoli during the therapy.”
D  “I should not use any acetaminophen during the therapy.”
Question #29
A  “I should keep taking ibuprofen for my arthritis.”
B  “I will double my dose if I forget to take it the day before.”
C  “I should decrease the dose if I start bruising easily.”
D  “I should use a soft toothbrush for dental hygiene.”
Question #30
A  “There is no real difference; dalteparin is interchangeable with regular heparin.”
B  “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
C  “The only difference is that regular heparin dosing is based on the patient’s weight.”
D  “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
Question #31
A  Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
B  Rub the administration site after injecting.
C  Utilize the Z-track method to inject the medication.
D  Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A  “I will contact my health care provider if I develop excessive bruising.”
B  “I will take my medication at the same time each day.”
C  “I will increase dark green leafy vegetables in my diet.”
D  “I will avoid contact sports.”
Question #34
A  Vitamin K daily
B  Warfarin daily
C  Recombinant factors
D  Aspirin daily (i.e., 81 mg)
Question #35
A  Peripheral vascular disease
B  Vitamin K deficiency
C  Acute unstable angina
D  Transient ischemic attack
Question #36
A  Heparin subcutaneously
B  Warfarin orally
C  Enoxaparin intramuscularly
D  Dabigatran orally
Question #37
A  Ingestion of acetaminophen
B  Over-the-counter medications
C  Platelet level
D  Urine culture
Question #40
A  Blood urea nitrogen (BUN) level of 12 mg/dL
B  International normalized ratio (INR) of 1.0
C  Activated partial thromboplastin time (aPTT) of 120 seconds
D  Platelet count of 150,000 mm3
Question #41
A  Hemoglobin level of 16.5 g/dL
B  Creatinine clearance value of 40 mL/min
C  Fasting blood glucose level of 95 mg/dL
D  Platelet count of 75,000 cell/μL
Question #42
A  Antithrombin III
B  Vitamin K
C  Thrombin
D  Factor Xa
Question #43
A  Tranexamic acid
B  Alteplase
C  Desmopressin
D  Aminocaproic acid
Question #44
A  Antifibrinolytic
B  Antiplatelet
C  Thrombolytic
D  Anticoagulant
Question #45
A  Coronary artery disease
B  Heart failure
C  Cardiomyopathy
D  Acute myocardial infarction
Question #47
A  Fondaparinux
B  Argatroban
C  Dabigatran
D  Enoxaparin
Question #48
A  Selective factor Xa inhibitors
B  Direct thrombin inhibitors
C  Heparins
D  Warfarin
Question #49
A  Anticoagulants dissolve clots.
B  Anticoagulants alter platelet function.
C  Anticoagulants interfere with drug metabolism.
D  Anticoagulants prevent clots from forming.
Question #50
A  Thrombolytic
B  Anticoagulant
C  Antiplatelet
D  Antifibrinolytic
Question #51
A  Embolus to the lungs
B  Medication reaction
C  Anxiety
D  Fatigue from walking with pain
Question #52
A  Increasing the dose of enoxaparin
B  Administering vitamin K1
C  Infusing 50 mL of warfarin sodium
D  Administering protamine sulfate